Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease.

Van Remoortel H, Hornikx M, Langer D, Burtin C, Everaerts S, Verhamme P, Boonen S, Gosselink R, Decramer M, Troosters T, Janssens W.

Am J Respir Crit Care Med. 2014 Jan 1;189(1):30-8. doi: 10.1164/rccm.201307-1240OC.

PMID:
24219412
2.

Physical comorbidities affect physical activity in chronic obstructive pulmonary disease: a prospective cohort study.

McNamara RJ, McKeough ZJ, McKenzie DK, Alison JA.

Respirology. 2014 Aug;19(6):866-72. doi: 10.1111/resp.12325. Epub 2014 Jun 9.

3.

Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study).

de Lucas-Ramos P, Izquierdo-Alonso JL, Rodriguez-Gonzalez Moro JM, Frances JF, Lozano PV, Bellón-Cano JM; CONSISTE study group.

Int J Chron Obstruct Pulmon Dis. 2012;7:679-86. doi: 10.2147/COPD.S36222. Epub 2012 Oct 1.

4.

Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study.

Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H.

Am J Respir Crit Care Med. 2008 Apr 1;177(7):743-51. Epub 2007 Nov 29.

PMID:
18048807
5.

Gender and chronic obstructive pulmonary disease in high-risk smokers.

de Torres JP, Campo A, Casanova C, Aguirre-Jaime A, Zulueta J.

Respiration. 2006;73(3):306-10. Epub 2005 Nov 29.

PMID:
16330871
6.

Chronic pain and pain medication use in chronic obstructive pulmonary disease. A cross-sectional study.

Roberts MH, Mapel DW, Hartry A, Von Worley A, Thomson H.

Ann Am Thorac Soc. 2013 Aug;10(4):290-8. doi: 10.1513/AnnalsATS.201303-040OC.

PMID:
23952846
7.

Chronic obstructive pulmonary disease as comorbidity in patients admitted to a university hospital: a cross-sectional study.

Nielsen HM, Rødsgaard PA, Weinreich UM.

Clin Respir J. 2014 Jul;8(3):274-80. doi: 10.1111/crj.12050. Epub 2014 Apr 29.

PMID:
23911061
8.

Impact of comorbidities on physical activity in COPD.

Sievi NA, Senn O, Brack T, Brutsche MH, Frey M, Irani S, Leuppi JD, Thurnheer R, Franzen D, Kohler M, Clarenbach CF.

Respirology. 2015 Apr;20(3):413-8. doi: 10.1111/resp.12456. Epub 2015 Jan 6.

9.

Prevalence of chronic obstructive pulmonary disease among smokers attending primary healthcare clinics in Saudi Arabia.

Al Ghobain M, Al-Hajjaj MS, Wali SO.

Ann Saudi Med. 2011 Mar-Apr;31(2):129-33. doi: 10.4103/0256-4947.77485.

10.

[Cardiovascular risk factors in chronic obstructive pulmonary disease: results of the ARCE study].

de Lucas-Ramos P, Izquierdo-Alonso JL, Rodríguez-González Moro JM, Bellón-Cano JM, Ancochea-Bermúdez J, Calle-Rubio M, Calvo-Corbella E, Molina-París J, Pérez-Rodríguez E, Pons S.

Arch Bronconeumol. 2008 May;44(5):233-8. Spanish.

11.

[Prevalence of chronic obstructive pulmonary disease and risk factors in smokers and ex-smokers].

Jaén Díaz JI, de Castro Mesa C, Gontán García-Salamanca MJ, López de Castro F.

Arch Bronconeumol. 2003 Dec;39(12):554-8. Spanish.

12.

Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.

Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, Chen B, Wang C, Ni D, Zhou Y, Liu S, Wang X, Wang D, Lu J, Zheng J, Ran P.

Am J Respir Crit Care Med. 2007 Oct 15;176(8):753-60. Epub 2007 Jun 15. Erratum in: Am J Respir Crit Care Med. 2007 Dec 1;176(11):1169.

PMID:
17575095
13.

Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.

Miniati M, Monti S, Basta G, Cocci F, Fornai E, Bottai M.

Respir Res. 2011 Mar 30;12:37. doi: 10.1186/1465-9921-12-37.

14.

[Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].

Sleszycka J, Woźniak K, Banaszek M, Wiechno W, Domagała-Kulawik J.

Pol Merkur Lekarski. 2009 Aug;27(158):92-6. Polish.

PMID:
19856871
15.

Burden of obstructive lung disease in a rural setting in the Philippines.

Idolor LF, DE Guia TS, Francisco NA, Roa CC, Ayuyao FG, Tady CZ, Tan DT, Banal-Yang S, Balanag VM Jr, Reyes MT, Dantes RB.

Respirology. 2011 Oct;16(7):1111-8. doi: 10.1111/j.1440-1843.2011.02027.x.

PMID:
21801277
16.

Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors.

Izquierdo JL, Martínez A, Guzmán E, de Lucas P, Rodríguez JM.

Int J Chron Obstruct Pulmon Dis. 2010 Nov 8;5:387-94.

17.

Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.

Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM.

Am J Respir Crit Care Med. 2007 Mar 1;175(5):458-63. Epub 2006 Dec 7.

PMID:
17158282
18.

Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies.

Lundbäck B, Lindberg A, Lindström M, Rönmark E, Jonsson AC, Jönsson E, Larsson LG, Andersson S, Sandström T, Larsson K; Obstructive Lung Disease in Northern Sweden Studies.

Respir Med. 2003 Feb;97(2):115-22.

PMID:
12587960
19.

Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study.

López Varela MV, Montes de Oca M, Halbert R, Muiño A, Tálamo C, Pérez-Padilla R, Jardim JR, Valdivia G, Pertuzé J, Menezes AM; PLATINO team.

Arch Bronconeumol. 2013 Nov;49(11):468-74. doi: 10.1016/j.arbres.2013.05.003. Epub 2013 Jul 13. English, Spanish.

20.

Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era?

Madeddu G, Fois AG, Calia GM, Babudieri S, Soddu V, Becciu F, Fiori ML, Spada V, Lovigu C, Mannazzu M, Caddeo A, Piras B, Pirina P, Mura MS.

Infection. 2013 Apr;41(2):347-53. doi: 10.1007/s15010-012-0330-x. Epub 2012 Sep 13.

PMID:
22971938

Supplemental Content

Support Center